Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Public Health Research. 2014, 2(5), 205-210
DOI: 10.12691/AJPHR-2-5-4
Original Research

Dyspnea in Cancer Patients Undergoing Chemotherapy and Its Impact on Quality of Life in Northern Greece

Maria Lavdaniti1, , Maria Tsiligiri2 and Sofia Zyga3

1Assistant Professor Nursing Department, Alexander Technological Educational Institute of Thessaloniki, Greece

2Associate Professor, Physical Therapy Department, Alexander Technological Educational Institute of Thessaloniki, Greece

3Associate Professor, Faculty of Human Movement and Quality of Life Sciences, Department of Nursing, University of Peloponnese, Sparta, Greece

Pub. Date: November 03, 2014
Full Text PDF

Cite this paper

Maria Lavdaniti, Maria Tsiligiri and Sofia Zyga. Dyspnea in Cancer Patients Undergoing Chemotherapy and Its Impact on Quality of Life in Northern Greece. American Journal of Public Health Research. 2014; 2(5):205-210. doi: 10.12691/AJPHR-2-5-4

Abstract

Objective: The purpose of this study was to assess dyspnea in cancer patients undergoing chemotherapy and to determine whether dyspnea affects patients’ quality of life. Method: This study was descriptive and non-experimental. Two scales were used for the selection of the sample. Subjects were assessed for their dyspnea based on the Memorial Symptom Assessment Scale (MSAS) and for quality of life using the Functional Assessment of Cancer Therapy-General (FACT-G). Data collection was carried out during the third cycle of chemotherapy. Results: The mean age of patients was 58.95 ± 9.95 years. The majority of patients were male and married. 30% of patients belonging to the sample examined suffered from dyspnea. A percentage of 33.3% frequently experienced shortness of breath. With respect to severity, 31.7% replied that the symptom was severe; it was quite distressing for 21.7% of the sample and somewhat distressing for 18.5% of all patients. Logistic regression analysis showed that the statistically significant factors influencing dyspnea are age (p = 0.004) and gender (p = 0.030). Conclusions: Dyspnea is a symptom appearing in cancer patients during chemotherapy and it affects patients’ quality of life. This finding is very significant for Greek nurses seeking to recognize and assess this symptom in clinical settings. The recognition and evaluation of the symptom by nurses can lead to increased continuity in nursing care and to planned interventions to alleviate it.

Keywords

dyspnea, cancer, chemotherapy, quality of life, Greece

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Globocan 2012: Estimated Cancer Incidence Mortality and Incidence worldwide in 2012. Available at http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx Αccessed 30 march 2014
 
[2]  Globocan 2008: Cancer incidence and mortality worldwide. Available at www.iarc.fr. Αccessed 30 march 2014.
 
[3]  Deshields, T.L., Potter, P., Olsen, S., Liu, J. The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer, 22 (4). 1089-96. Apr. 2014.
 
[4]  Quast, E., Williams, M. Distress with Breathing in People with Lung Cancer: A Systematic Review. The Internet Journal of Allied Health Sciences and Practice. 7 (4). Oct. 2009.
 
[5]  Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. American Journal of Respiratory Critical Care Medicine, 159 (1). 321-40, Jan. 1999.
 
[6]  Glennon, C., Seskevich, J. Relaxation technique to ease dyspnea: a tool for oncology nurses. Clinical Journal of Oncology Nursing, 12 (2). 369-71. Apr. 2008.
 
[7]  DiSalvo, W.M., Joyce, M.M., Tyson, L.B., Culkin, A.B., Mackay, K. Putting evidence into practice: Evidence-based interventions for cancer-related dyspnoea. Clinical Journal of Oncology Nursing, 12. 241-352. Apr. 2008.
 
[8]  DeVita, V.T. Jr, Chu, E. A history of cancer chemotherapy. Cancer Research, 68 (21). 8643-53. Nov. 2008.
 
[9]  Corner J, Bailey C. Cancer nuring: care in context. 2006. Blackwell science.
 
[10]  Singh, H., Kaur, K., Banipal, R.P., Singh, S., Bala, R. Quality of life in cancer patients undergoing chemotherapy in tertiary care center in malwa region of punjab. Indian Journal of Palliative Care, 20 (2). 116-22. May. 2014.
 
[11]  WHOQOL Group. Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Quality of Life Research, 2 (2). 153-159. Apr 1993.
 
[12]  Smith, E.L., Hann, D.M., Ahles, T.A., Furstenberg, C.T., Mitchell, T.A., Meyer, L., Maurer, L.H., Rigas, J., Hammond, S. Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. Journal of Pain &Symptom Management, 21 (4). 323-9. Apr. 2001.
 
[13]  Hui, D., Morgado, M., Vidal, M, Withers L, Nguyen Q, Chisholm G, Finch C, Bruera E. Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. Journal of Palliative Medicine, 16 (3). 274-80. Mar. 2013.
 
[14]  Rhondali, W., Hui, D., Kim, S.H., Kilgore, K., Kang, J.H., Nguyen L, Bruera E. Association between patient-reported symptoms and nurses' clinical impressions in cancer patients admitted to an acute palliative care unit. Journal of Palliative Medicine, 15 (3). 301-7. Mar. 2012.
 
[15]  Aeckerle, S., Moor, M., Pilz, L.R., Gencer, D., Hofheinz, R.D., Hofmann, W.K., Buchheidt D. Characteristics, treatment and prognostic factors of patients with gynaecological malignancies treated in a palliative care unit at a university hospital. Onkologie, 36 (11). 642-8. Oct. 2013.
 
[16]  Cui, J., Fang, F., Shen, F., Song, L., Zhou, L., Ma, X., Zhao, J. Quality of Life in Patients With Advanced Cancer at the End of Life as Measured by the McGill Quality of Life Questionnaire: A Survey in China. Journal of Pain and Symptom Management, May 2014 2. pii: S0885-3924 (14) 00229-2.
 
[17]  Rupolo, M., Lleshi, A., Cacopardo, B., Michieli, M., Berretta, M. Hematopoietic growth factors support in the elderly cancer patients treated with antiblastic chemotherapy. Anticancer Agents in Medical Chemistry, 13 (9): 1438-43, Nov 2013.
 
[18]  Ellis, J., Wagland, R., Tishelman, C., Williams, M.L., Bailey, C.D., Haines, J., Caress, A., Lorigan, P., Smith, J.A., Booton, R., Blackhall, F., Molassiotis, A. Considerations in developing and delivering a nonpharmacological intervention for symptom management in lung cancer: the views of patients and informal caregivers. Journal of Pain and Symptom Management, 44 (6): 831-42. Dec. 2012.
 
[19]  Morita, T., Kuriya, M., Miyashita, M., Sato, K., Eguchi, K., Akechi, T. Symptom burden and achievement of good death of elderly cancer patients. Journal of Palliative Medicine, 217 (8). 887-93. Aug. 2014.
 
[20]  Koelwyn, G.J., Jones, L.W., Hornsby, W., Eves, N.D. Exercise therapy in the management of dyspnea in patients with cancer. Curr Opin Support Palliat Care, 6 (2). 129-37. Jun. 2012.
 
[21]  Hallqvist, A., Bergman, B., Nyman, J. Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials. Radiotherapy and Oncology, 104 (1). 39-44. Jul. 2012.
 
[22]  Yang, J.C., Hirsh, V., Schuler, M., Yamamoto, N., O'Byrne, K.J., Mok, T.S., Zazulina, V., Shahidi, M., Lungershausen, J., Massey, D., Palmer, M., Sequis,t L.V. Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/ pemetrexed in patientswith advanced lung adenocarcinoma with EGFR mutations. Journal of Clinical Oncology, 31 (27). 3342-50. Sep. 2013.
 
[23]  Hirsh, V., Cadranel, J., Cong, X.J., Fairclough, D., Finnern, H.W., Lorence, R.M., Miller, V.A., Palmer M, Yang JC. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1). Journal of Thoracic Oncology, 8 (2). 229-37. Feb. 2013.
 
[24]  Di Maio, M., Leighl, N.B., Gallo, C., Feld, R., Ciardiello, F., Butts, C., et al TORCH Investigators. Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer. Journal of Thoracic Oncology, 7 (12). 1830-44. Dec 2012.
 
[25]  Yildirim Y, Tokem Y, Bozkurt N, Fadiloglu C, Uyar M, Uslu R. Reliability and validity of the Turkish version of the Memorial Symptom Assessment Scale in cancer patients. Asian Pacific Journal of Cancer Prevention, 12 (12). 3389-96. 2011.
 
[26]  Paice JA. Assessment of symptom clusters in people with cancer. Journal of the National Cancer Institute Monographs, (32). 98-102. 2004.
 
[27]  Portenoy, R.K., Thaler, H.T., Kornblith, A.B., Lepore, J.M., Friedlander-Klar, H., Kiyasu, E., Sobel, K., Coyle, N., Kemeny, N., Norton, L., et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer, 30A (9): 1326-36. 1994.
 
[28]  Functional Assessment of Cancer Therapy-General (FACT-G). Available at: www.facit.org, access 30 March 2014.
 
[29]  Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J.W.W., Comber, H., Forman, D., Bray, F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. European Journal of Cancer, 49 (6). 1374-403. Apr. 2013.
 
[30]  Pettersson, G., Berterö, C., Unosson, M., Börjeson, S. Symptom prevalence, frequency, severity, and distress during chemotherapy for patients with colorectal cancer. Support Care Cancer, 22 (5). 1171-9. May. 2014.
 
[31]  Nazik, E., Arslan, S., Nazik, H., Narin, M.A., Karlangic, H., Koc, Z. Anxiety and symptom assessment in Turkish gynecologic cancer patients receiving chemotherapy. Asian Pacific Journal of Cancer Prevention, 13 (7). 3129-33. 2012.
 
[32]  Bausewein, C., Simon, S.T. Shortness of breath and cough in patients in palliative care. Dtsch Arztebl Int, 110 (33−34). 563-72. 2013.
 
[33]  Mercadante, S., Casuccio, A., Fulfaro, F. The course of symptom frequency and intensity in advanced cancer patients followed at home. Journal of Pain Symptom Management, 20 (2). 104-12. Aug. 2000.
 
[34]  Mc Call, S. Management of dyspnea in cancer patients.Available at: http://www.oncolink.org/resources/article.cfm?id=1052, accessed 10 July 2014.
 
[35]  Reddy, S.K., Parsons, H.A., Elsayem, A., Palmer, J.L., Bruera, E. Characteristics and correlates of dyspnea in patients with advanced cancer. Palliatiative Medicine, 12 (1). 29-36. Jan. 2009.
 
[36]  Bruera, E., Schmitz, B., Pither, J., Neumann, C.M., Hanson, J. The frequency and correlates of dyspnea in patients with advanced cancer. Journal of Pain and Symptom Management, 19 (5): 357-62. May. 2000.